Atlas Trials

Predictive Value of Analysing Tissue From Patients With Metastatic Pancreatic Cancer for Drug Sensitivity

Clinical trial NCT03821870 · COMPLETED

Trial details

NCT number
NCT03821870
Sponsor
Vejle Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Pancreatic Cancer
Start date
2019-02-25
Primary completion
2021-12-31
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.